Health

Vitamin D deficiency is widely overestimated, doctors warn

Doctors are warning about vitamin D again, and it's not the "we need more" news you might expect. Instead, they say there's too much needless testing and too many people taking too many pills for a problem that few people ...

Oncology & Cancer

New findings on prostate cancer screening

The prostate-specific antigen test for prostate cancer was developed in the 1990s, quickly followed by an explosion of PSA screening for the disease and a further explosion of treatment. Treatment consists of either radiation ...

Oncology & Cancer

Drop in use of digital rectal examination, PSA testing

(HealthDay)—Following U.S. Preventive Services Task Force (USPSTF) recommendations against routine prostate-specific antigen (PSA) screening, there has been a decrease in utilization of digital rectal examination and PSA ...

Oncology & Cancer

Treat or monitor early prostate cancer? 10-yr survival same

Men with early prostate cancer who choose to closely monitor their disease are just as likely to survive at least 10 years as those who have surgery or radiation, finds a major study that directly tested and compared these ...

Oncology & Cancer

Metastatic prostate cancer cases skyrocket

The number of new cases of metastatic prostate cancer climbed 72 percent in the past decade from 2004 to 2013, reports a new Northwestern Medicine study. The report considers whether a recent trend of fewer men being screened ...

Oncology & Cancer

Agreement high for prognostic cancer screening tools

(HealthDay)—For cancer screening in Medicare beneficiaries, there is substantial agreement for different prognostic tools for short- and long-term survival, according to a study published online April 30 in the Journal ...

page 10 from 25